Unveiling the pathogenesis and therapeutic strategies of Alzheimer’s disease through cuproptosis
- 18 June 2026
- journal article
- review article
- Published by Springer Nature in BioMetals
- Vol. 39 (5) , 1-24
Abstract
Alzheimer’s disease (AD), a leading cause of dementia, remains incurable, necessitating novel insights into its pathogenesis and therapeutic strategies. Recent studies highlight cuproptosis—a copper (Cu)-dependent mitochondrial cell death pathway—as a critical player in AD progression. Cuproptosis is triggered by Cu overload, which disrupts mitochondrial tricarboxylic acid cycle enzymes, resulting in toxic aggregation of lipoylated proteins and iron-sulfur cluster destabilization. This process exacerbates mitochondrial dysfunction, oxidative stress, and neuronal loss, synergizing with hallmark AD pathologies like Aβ deposition and Tau hyperphosphorylation. Unlike ferroptosis or apoptosis, cuproptosis uniquely involves mitochondrial protein lipoylation and Cu homeostasis imbalance. Therapeutic strategies targeting cuproptosis include Cu chelators, inhibitors of Cu transporters, antioxidants, and gene editing approaches to restore Cu homeostasis or mitigate protein aggregation. Immunotherapy and neuroprotective agents further show promise in alleviating cuproptosis-driven neuroinflammation. Despite preclinical advancements, challenges remain in balancing Cu’s essential roles with therapeutic interventions. This review underscores cuproptosis as a pivotal mechanism in AD and outlines emerging therapeutic avenues, emphasizing the ncessity for precision in targeting Cu dysregulation to halt neurodegeneration.Keywords
This publication has 103 references indexed in Scilit:
- How brain ‘cleaners’ fail: Mechanisms and therapeutic value of microglial phagocytosis in Alzheimer's diseaseGlia, 2023
- Apoptosis in Alzheimer’s disease: insight into the signaling pathways and therapeutic avenuesApoptosis, 2023
- Effects of risk factors on longitudinal changes in brain structure and function in the progression of ADAlzheimer's & Dementia, 2023
- Critical appraisal on mitochondrial dysfunction in Alzheimer’s diseaseAging Medicine, 2022
- Dihydrolipoamide dehydrogenase, pyruvate oxidation, and acetylation-dependent mechanisms intersecting drug iatrogenesisCellular and Molecular Life Sciences, 2021
- Structural and Functional Diversity Among the Members of CTR, the Membrane Copper Transporter FamilyThe Journal of Membrane Biology, 2020
- Cell death: a review of the major forms of apoptosis, necrosis and autophagyCell Biology International, 2019
- Copper and Alzheimer’s Disease2017
- Detoxifying Polyhalogenated Catechols through a Copper-Chelating Agent by Forming Stable and Redox-Inactive Hydrogen-Bonded Complexes with an Unusual Perpendicular StructureChemistry – A European Journal, 2014
- An english translation of alzheimer's 1907 paper, “über eine eigenartige erkankung der hirnrinde”Clinical Anatomy, 1995